Tatva Chintan Pharma Chem share news, announcements and annual reports
NSE: TATVABSE: 543321Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,614.80.
30 Oct: open ₹1,624.90, high ₹1,659.00, low ₹1,582.10
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,845 Cr999th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 61.12
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.72
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.21
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 74,35445.2% delivered
Tatva Chintan Pharma Chem has 329 announcements on record, routine notices left out; 5 in the 30 days to 31 Oct 2026, the latest on 19 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Tatva Chintan Pharma Chem quarterly results
The board met on 19 Oct 2026 to consider financial results
Notice filed 12 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Tatva Chintan Pharma Chem annual reports, presentations and earnings calls
The company's own documents, latest first.Tatva Chintan Pharma Chem financials, year by year
Annual reports6
- Annual report, year to Mar 202627 Aug 2026
- Annual report, year to Mar 202526 Aug 2025
- Annual report, year to Mar 202424 Aug 2024
- Annual report, year to Mar 202326 Aug 2023, a zip file
- Annual report, year to Mar 202223 Aug 2022, a zip file
1 earlier report
- Annual report, year to Mar 20216 Sep 2021, a zip file
Investor presentations21
- Updated Investor Presentation.19 Oct 2026
- Investor Presentation19 Oct 2026
- Investor Presentation17 Jul 2026
- Investor Presentation16 May 2026
- Investor Presentation21 Jan 2026
16 earlier presentations
- Investor Presentation31 Oct 2025
- Investor Presentation24 Jul 2025
- Investor Presentation5 May 2025
- Investor Presentation28 Jan 2025
- Investor Presentation25 Oct 2024
- Investor Presentation24 Jul 2024
- Investor Presentation3 May 2024
- Investor Presentation20 Jan 2024
- Investor Presentation2 Nov 2023
- Investor Presentation4 Aug 2023
- Investor Presentation5 May 2023
- Investor Presentation24 Jan 2023
- Investor Presentation4 Nov 2022
- Investor Presentation25 Jul 2022
- Investor Presentation25 Apr 2022
- Investor Presentation18 Jan 2022
Earnings calls38
- Transcript21 Jul 2026
- Link of Recording17 Jul 2026
- Transcript19 May 2026
- Link of Recording16 May 2026
- Transcript24 Jan 2026
33 earlier call documents
- Link of Recording21 Jan 2026
- Transcript4 Nov 2025
- Link of Recording31 Oct 2025
- Transcript28 Jul 2025
- Link of Recording24 Jul 2025
- Transcript9 May 2025
- Link of Recording5 May 2025
- Transcript31 Jan 2025
- Link of Recording28 Jan 2025
- Transcript30 Oct 2024
- Link of Recording25 Oct 2024
- Transcript29 Jul 2024
- Link of Recording24 Jul 2024
- Transcript7 May 2024
- Link of Recording3 May 2024
- Transcript24 Jan 2024
- Link of Recording20 Jan 2024
- Transcript7 Nov 2023
- Link of Recording2 Nov 2023
- Transcript9 Aug 2023
- Link of Recording4 Aug 2023
- Transcript of Earnings Call held on 05 May 2023'.10 May 2023
- Link of Recording5 May 2023
- Transcript of Earnings Call held on 24 January 202330 Jan 2023
- Audio recording of Earnings Call24 Jan 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call8 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call4 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call29 Jul 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call25 Jul 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call28 Apr 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call25 Apr 2022
- Transcript22 Jan 2022
- Transcript29 Oct 2021
Tatva Chintan Pharma Chem share news and announcements
Newest first. Page 1 of 7.
Oct 2026
19 Oct · Results
16 Oct · Analysts
13 Oct · Analysts
12 Oct · Board meeting
Sep 2026
25 Sep · Meeting
17 Sep · Analysts
8 Sep · Analysts
8 Sep · Rating
Aug 2026
27 Aug · Corporate action
19 Aug · Management
19 Aug · Management
7 Aug · Analysts
3 Aug · Analysts
Jul 2026
31 Jul · Analysts
24 Jul · Analysts
24 Jul · Analysts
24 Jul · Analysts
22 Jul · Analysts
21 Jul · Analysts
17 Jul · Results
10 Jul · Analysts
10 Jul · Board meeting
Jun 2026
12 Jun · Analysts
May 2026
16 May · Results
6 May · Analysts
Apr 2026
29 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Mar 2026
19 Mar · Analysts
14 Mar · Analysts
11 Mar · Analysts
Feb 2026
18 Feb · Business
11 Feb · Analysts
Jan 2026
21 Jan · Results
12 Jan · Analysts
12 Jan · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 21 Oct 2026Resultsdown 0.70%+0.2 pts vs Nifty 500market median −0.7% · five sessions −15.7% (−14.3 pts vs Nifty 500) · volume 8.1× usual · delivery −22.1 pts against usual · The announcement
- 9 Sep 2026Credit ratingup 0.49%+1.1 pts vs Nifty 500market median 0.0% · five sessions −2.0% (+0.5 pts vs Nifty 500) · volume 0.7× usual · delivery +1.7 pts against usual · The announcement
- 20 Aug 2026Board or managers changeddown 0.57%−1.1 pts vs Nifty 500market median 0.0% · five sessions −2.5% (−3.3 pts vs Nifty 500) · volume 0.7× usual · delivery +8.7 pts against usual · The announcement
- 20 Jul 2026Resultsup 20.00%+20.0 pts vs Nifty 500market median −0.7% · five sessions +20.6% (+22.4 pts vs Nifty 500) · volume 58.0× usual · delivery −38.6 pts against usual · The announcement
- 18 May 2026Resultsdown 4.85%−4.5 pts vs Nifty 500market median −0.7% · five sessions −9.8% (−10.3 pts vs Nifty 500) · volume 3.1× usual · delivery −15.4 pts against usual · The announcement
- 22 Jan 2026Resultsdown 8.19%−9.0 pts vs Nifty 500market median −0.7% · five sessions −20.0% (−21.3 pts vs Nifty 500) · volume 11.4× usual · delivery −23.7 pts against usual · The announcement
- 3 Nov 2025Resultsdown 0.68%−1.1 pts vs Nifty 500market median −0.7% · five sessions +4.6% (+5.0 pts vs Nifty 500) · volume 2.1× usual · delivery −10.8 pts against usual · The announcement
- 25 Jul 2025Resultsup 12.83%+14.1 pts vs Nifty 500market median −0.7% · five sessions +14.9% (+16.6 pts vs Nifty 500) · volume 22.0× usual · delivery −24.7 pts against usual · The announcement
- 18 Jun 2025Credit ratingdown 1.11%−0.9 pts vs Nifty 500market median 0.0% · five sessions −2.8% (−3.4 pts vs Nifty 500) · volume 0.2× usual · delivery +4.1 pts against usual · The announcement
- 5 May 2025Resultsup 0.11%−0.8 pts vs Nifty 500market median −0.7% · five sessions +5.0% (+6.5 pts vs Nifty 500) · volume 2.5× usual · delivery −18.3 pts against usual · The announcement
14 earlier announcements
- 5 May 2025Dividendup 0.11%−0.8 pts vs Nifty 500market median 0.0% · five sessions +5.0% (+6.5 pts vs Nifty 500) · volume 2.5× usual · delivery −18.3 pts against usual · The announcement
- 7 Nov 2024Credit ratingup 4.62%+5.6 pts vs Nifty 500market median 0.0% · five sessions −2.8% (+2.0 pts vs Nifty 500) · volume 2.5× usual · delivery −27.4 pts against usual · The announcement
- 6 May 2024Dividenddown 2.32%−1.9 pts vs Nifty 500market median 0.0% · five sessions −7.4% (−5.1 pts vs Nifty 500) · volume 1.3× usual · delivery −5.0 pts against usual · The announcement
- 20 Jan 2024Resultsdown 2.11%−2.1 pts vs Nifty 500market median −0.7% · five sessions −9.5% (−10.1 pts vs Nifty 500) · volume 1.7× usual · delivery −29.9 pts against usual · The announcement
- 22 Sep 2023Credit ratingdown 0.41%−0.2 pts vs Nifty 500market median 0.0% · five sessions −3.1% (−2.4 pts vs Nifty 500) · volume 0.5× usual · delivery +21.8 pts against usual · The announcement
- 4 Aug 2023Resultsdown 0.75%−1.5 pts vs Nifty 500market median −0.7% · five sessions 0.0% (−1.0 pts vs Nifty 500) · volume 1.5× usual · delivery −22.4 pts against usual · The announcement
- 8 May 2023Dividenddown 8.11%−9.1 pts vs Nifty 500market median 0.0% · five sessions −11.2% (−12.5 pts vs Nifty 500) · volume 3.5× usual · delivery −12.5 pts against usual · The announcement
- 7 Jul 2022Credit ratingdown 0.03%−1.0 pts vs Nifty 500market median 0.0% · five sessions +0.6% (−0.1 pts vs Nifty 500) · volume 0.8× usual · delivery −21.4 pts against usual · The announcement
- 26 Apr 2022Dividenddown 7.44%−9.0 pts vs Nifty 500market median 0.0% · five sessions −7.5% (−8.0 pts vs Nifty 500) · volume 8.9× usual · delivery −11.6 pts against usual · The announcement
- 18 Jan 2022Resultsdown 9.00%−7.7 pts vs Nifty 500market median −0.7% · five sessions −14.7% (−7.9 pts vs Nifty 500) · volume 6.6× usual · delivery −10.1 pts against usual · The announcement
- 18 Jan 2022Board or managers changeddown 9.00%−7.7 pts vs Nifty 500market median 0.0% · five sessions −14.7% (−7.9 pts vs Nifty 500) · volume 6.6× usual · delivery −10.1 pts against usual · The announcement
- 25 Oct 2021Resultsup 8.30%+8.7 pts vs Nifty 500market median −0.7% · five sessions +17.3% (+19.4 pts vs Nifty 500) · volume 5.7× usual · delivery −20.1 pts against usual · The announcement
- 25 Aug 2021Board or managers changedup 2.21%+2.0 pts vs Nifty 500market median 0.0% · five sessions −3.9% (−7.4 pts vs Nifty 500) · delivery −19.3 pts against usual · The announcement
- 16 Aug 2021Resultsdown 1.38%−1.4 pts vs Nifty 500market median −0.7% · five sessions +1.2% (+2.1 pts vs Nifty 500) · delivery +0.8 pts against usual · The announcement
Tatva Chintan Pharma Chem results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.